2016
DOI: 10.1002/anie.201602880
|View full text |Cite
|
Sign up to set email alerts
|

Catalytic Asymmetric Inverse‐Electron‐Demand 1,3‐Dipolar Cycloaddition of C,N‐Cyclic Azomethine Imines with Azlactones: Access to Chiral Tricyclic Tetrahydroisoquinolines

Abstract: Reported herein is a bifunctional-organocatalyst-mediated enantioselective inverse-electron-demand 1,3-dipolar cycloaddition of C,N-cyclic azomethine imines with azlactones. The strategy provides concise access to enantioenriched C1-substituted tetrahydroisoquinolines featuring a pyrazolidinone scaffold. Moreover, the scalability and practical utility of this protocol was well demonstrated by employing a gram-scale reaction and some representative transformations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(12 citation statements)
references
References 74 publications
0
12
0
Order By: Relevance
“…This is of particular importance, because such asymmetric reactions would allow for the preparation of analogues of Eli-Lilly’s γ-lactam antibiotics. On the other hand, the majority of catalytic asymmetric [3+2] cycloadditions of azomethine imines to alkenes have been performed using various organocatalysts, although examples of transition-metal-catalyzed reactions have also been reported [ 11 , 37 , 38 , 57 ]. The use of other dipolarophiles, such as cumulenes, imines, thiones, and nitriles, is another unexplored field of asymmetric cycloadditions of azomethine imines.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is of particular importance, because such asymmetric reactions would allow for the preparation of analogues of Eli-Lilly’s γ-lactam antibiotics. On the other hand, the majority of catalytic asymmetric [3+2] cycloadditions of azomethine imines to alkenes have been performed using various organocatalysts, although examples of transition-metal-catalyzed reactions have also been reported [ 11 , 37 , 38 , 57 ]. The use of other dipolarophiles, such as cumulenes, imines, thiones, and nitriles, is another unexplored field of asymmetric cycloadditions of azomethine imines.…”
Section: Discussionmentioning
confidence: 99%
“…In general, azlactones prepared from different amino acids were very well tolerated, as well as azlactones containing diverse (hetero)aryl substituents in the C2-position. Azomethine imines with different substituents on the aromatic ring and various substituents at the 4-position of the phenyl ring of the arylsulfonyl protecting group were very well compatible with the developed protocol ( Scheme 34 ) [ 57 ].…”
Section: Synthesis Of Pyrazolidinesmentioning
confidence: 99%
“…In 2016, Su, Liu, and co-workers reported that the chiral thiourea catalyzed double-activation mode was applied to promote the asymmetric IED cycloadditions of azomethine imines with azlactones (Scheme 17). 46 As azlactones [47][48][49][50] contain multiple reactive sites enabling either [3+3] or [3+2] cycloadditions, two kinds of conceivable cycloaddition product structure were proposed. After careful study followed by optimization, it was shown that the [3+2] cycloadducts, enantioenriched C 1 -substituted pyrazolidinefused THIQs 39 were obtained in high yields and with good to excellent diastereo-and enantioselectivities using bifunctional organocatalyst C13.…”
Section: Ied [3+2] Cycloaddition Of Cn-cyclic N′-acyl Azomethine Iminesmentioning
confidence: 99%
“…In the case of reaction with imines, excellent progress has been made with Mannich reactions (C4) or 1,3‐dipolar cycloaddition (C4 and C2),, but [2+2] cyclizations (C4 and C5) have been extremely limited. Motivated by the previous work on [2+3] cyclization with azomethine imines and our interest in azlactones,, we wondered whether the right choice of imine and catalyst could ensure that azlactones undergo [2+2] cyclization with imines to give α‐amino‐β‐lactams.…”
Section: Figurementioning
confidence: 99%